Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Merseburger

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Der Urologe. Ausg. A|July 12, 2019
[Molecular tumor board in uro-oncology]H Kübler, A S Merseburger
Der Urologe. Ausg. A|September 5, 2015
[Urological Clinic of the University Hospital of Lübeck: Founding and history of the urology department in the second half of the 20th century]P Latz, A S Merseburger
Der Urologe. Ausg. A|June 11, 2020
[Treatment of oligo- and advanced metastatic prostate cancer]B A Hadaschik, A S Merseburger
Der Urologe. Ausg. A|July 1, 2008
[Value of targeted therapies for renal cell cancer]A S Merseburger, M A Kuczyk
Der Urologe. Ausg. A|April 11, 2020
[Treatment of metastatic, castration-resistant prostate cancer]G von Amsberg, A S Merseburger
Der Urologe. Ausg. A|April 18, 2007
[Efficacy of multikinase inhibitors in the treatment of advanced renal cell cancer. A snapshot]M Kuczyk, S Kruck, A S Merseburger
Der Urologe. Ausg. A|December 11, 2008
[Value of lymph node dissection for renal cell carcinoma]I Matuschek, A S Merseburger, M A Kuczyk
Der Urologe. Ausg. A|August 12, 2009
[Current state of systemic therapy of metastatic renal cell carcinoma]A S Merseburger, S Waalkes, M A Kuczyk
Der Urologe. Ausg. A|March 19, 2017
[Should cytoreductive nephrectomy be performed in patients with metastatic renal cell carcinoma and what is the scientific rationale?]N Gilbert, A S Merseburger, M W Kramer
Der Urologe. Ausg. A|April 20, 2006
[Systemic therapy of malignant adrenal tumors]M Horstmann, A S Merseburger, A Stenzl, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Der Urologe. Ausg. A|July 12, 2019
[Molecular tumor board in uro-oncology]H Kübler, A S Merseburger
Der Urologe. Ausg. A|September 5, 2015
[Urological Clinic of the University Hospital of Lübeck: Founding and history of the urology department in the second half of the 20th century]P Latz, A S Merseburger
Der Urologe. Ausg. A|June 11, 2020
[Treatment of oligo- and advanced metastatic prostate cancer]B A Hadaschik, A S Merseburger
Der Urologe. Ausg. A|July 1, 2008
[Value of targeted therapies for renal cell cancer]A S Merseburger, M A Kuczyk
Der Urologe. Ausg. A|April 11, 2020
[Treatment of metastatic, castration-resistant prostate cancer]G von Amsberg, A S Merseburger
Der Urologe. Ausg. A|April 18, 2007
[Efficacy of multikinase inhibitors in the treatment of advanced renal cell cancer. A snapshot]M Kuczyk, S Kruck, A S Merseburger
Der Urologe. Ausg. A|December 11, 2008
[Value of lymph node dissection for renal cell carcinoma]I Matuschek, A S Merseburger, M A Kuczyk
Der Urologe. Ausg. A|August 12, 2009
[Current state of systemic therapy of metastatic renal cell carcinoma]A S Merseburger, S Waalkes, M A Kuczyk
Der Urologe. Ausg. A|March 19, 2017
[Should cytoreductive nephrectomy be performed in patients with metastatic renal cell carcinoma and what is the scientific rationale?]N Gilbert, A S Merseburger, M W Kramer
Der Urologe. Ausg. A|April 20, 2006
[Systemic therapy of malignant adrenal tumors]M Horstmann, A S Merseburger, A Stenzl, et al.
Pageof 8